Cargando…

Can Serum 25-Hydroxy Vitamin D Levels Predict the Severity of Multisystem Inflammatory Syndrome in Children and COVID-19?

OBJECTIVE: To determine the clinical significance of serum 25-hydroxy (OH) vitamin D levels in pediatric patients with multisystem inflammatory syndrome in children (MIS-C) and compare the vitamin D levels of these patients with those patients with Coronavirus disease-2019 (COVID-19) and healthy con...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekemen Keleş, Yıldız, Yılmaz, Dilek, Taşar, Selin, Üstündağ, Gülnihan, Şahin, Aslıhan, Tuz, Ayşegül Elvan, Arslan Maden, Aslıhan, Kara Aksay, Ahu, Çolak, Ayfer, Karadağ Öncel, Eda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234062/
https://www.ncbi.nlm.nih.gov/pubmed/36794864
http://dx.doi.org/10.4274/jcrpe.galenos.2023.2022-10-1
_version_ 1785052399067463680
author Ekemen Keleş, Yıldız
Yılmaz, Dilek
Taşar, Selin
Üstündağ, Gülnihan
Şahin, Aslıhan
Tuz, Ayşegül Elvan
Arslan Maden, Aslıhan
Kara Aksay, Ahu
Çolak, Ayfer
Karadağ Öncel, Eda
author_facet Ekemen Keleş, Yıldız
Yılmaz, Dilek
Taşar, Selin
Üstündağ, Gülnihan
Şahin, Aslıhan
Tuz, Ayşegül Elvan
Arslan Maden, Aslıhan
Kara Aksay, Ahu
Çolak, Ayfer
Karadağ Öncel, Eda
author_sort Ekemen Keleş, Yıldız
collection PubMed
description OBJECTIVE: To determine the clinical significance of serum 25-hydroxy (OH) vitamin D levels in pediatric patients with multisystem inflammatory syndrome in children (MIS-C) and compare the vitamin D levels of these patients with those patients with Coronavirus disease-2019 (COVID-19) and healthy controls. METHODS: This study was designed for pediatric patients aged 1 month to 18 years and conducted between July 14 and December 25, 2021. Fifty-one patients with MIS-C, 57 who were hospitalized with COVID-19, and 60 controls were enrolled in the study. Vitamin D insufficiency was defined as a serum 25 (OH) vitamin D level of less than 20 ng/mL. Severe MIS-C was classified as necessitating intensive care due to cardiovascular instability, the necessity for non-invasive or invasive mechanical ventilation, and/or a diminishing Glasgow coma scale. World Health Organization definition criteria were used to describe the clinical stages of COVID-19 in children and patients were divided into four groups according to the clinical severity of COVID-19: asymptomatic, mild, moderate, and severe/critical. RESULTS: The median serum 25 (OH) vitamin D was 14.6 ng/mL in patients with MIS-C, 16 ng/mL in patients with COVID-19, and 21.1 ng/mL in the control group (p<0.001). Vitamin D insufficiency was present in 74.5% (n=38) of patients with MIS-C, 66.7% (n=38) of patients with COVID-19, and 41.7% (n=25) of the controls (p=0.001). The percentage of four or more affected organ systems was 39.2% in patients with MIS-C. The correlation between the number of affected organ systems and serum 25 (OH) vitamin D levels was evaluated in patients with MIS-C and there was a moderate negative correlation (r=-0.310; p=0.027). A weak negative correlation was found between the severity of COVID-19 and serum 25 (OH) vitamin D (r=-0.320, p=0.015). CONCLUSION: Vitamin D levels were insufficient in both the MIS-C and COVID groups. Furthermore, vitamin D levels correlated with the number of affected organ systems in MIS-C and the severity of COVID-19.
format Online
Article
Text
id pubmed-10234062
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-102340622023-06-02 Can Serum 25-Hydroxy Vitamin D Levels Predict the Severity of Multisystem Inflammatory Syndrome in Children and COVID-19? Ekemen Keleş, Yıldız Yılmaz, Dilek Taşar, Selin Üstündağ, Gülnihan Şahin, Aslıhan Tuz, Ayşegül Elvan Arslan Maden, Aslıhan Kara Aksay, Ahu Çolak, Ayfer Karadağ Öncel, Eda J Clin Res Pediatr Endocrinol Original Article OBJECTIVE: To determine the clinical significance of serum 25-hydroxy (OH) vitamin D levels in pediatric patients with multisystem inflammatory syndrome in children (MIS-C) and compare the vitamin D levels of these patients with those patients with Coronavirus disease-2019 (COVID-19) and healthy controls. METHODS: This study was designed for pediatric patients aged 1 month to 18 years and conducted between July 14 and December 25, 2021. Fifty-one patients with MIS-C, 57 who were hospitalized with COVID-19, and 60 controls were enrolled in the study. Vitamin D insufficiency was defined as a serum 25 (OH) vitamin D level of less than 20 ng/mL. Severe MIS-C was classified as necessitating intensive care due to cardiovascular instability, the necessity for non-invasive or invasive mechanical ventilation, and/or a diminishing Glasgow coma scale. World Health Organization definition criteria were used to describe the clinical stages of COVID-19 in children and patients were divided into four groups according to the clinical severity of COVID-19: asymptomatic, mild, moderate, and severe/critical. RESULTS: The median serum 25 (OH) vitamin D was 14.6 ng/mL in patients with MIS-C, 16 ng/mL in patients with COVID-19, and 21.1 ng/mL in the control group (p<0.001). Vitamin D insufficiency was present in 74.5% (n=38) of patients with MIS-C, 66.7% (n=38) of patients with COVID-19, and 41.7% (n=25) of the controls (p=0.001). The percentage of four or more affected organ systems was 39.2% in patients with MIS-C. The correlation between the number of affected organ systems and serum 25 (OH) vitamin D levels was evaluated in patients with MIS-C and there was a moderate negative correlation (r=-0.310; p=0.027). A weak negative correlation was found between the severity of COVID-19 and serum 25 (OH) vitamin D (r=-0.320, p=0.015). CONCLUSION: Vitamin D levels were insufficient in both the MIS-C and COVID groups. Furthermore, vitamin D levels correlated with the number of affected organ systems in MIS-C and the severity of COVID-19. Galenos Publishing 2023-06 2023-05-29 /pmc/articles/PMC10234062/ /pubmed/36794864 http://dx.doi.org/10.4274/jcrpe.galenos.2023.2022-10-1 Text en ©Copyright 2023 by Turkish Pediatric Endocrinology and Diabetes Society | The Journal of Clinical Research in Pediatric Endocrinology published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ekemen Keleş, Yıldız
Yılmaz, Dilek
Taşar, Selin
Üstündağ, Gülnihan
Şahin, Aslıhan
Tuz, Ayşegül Elvan
Arslan Maden, Aslıhan
Kara Aksay, Ahu
Çolak, Ayfer
Karadağ Öncel, Eda
Can Serum 25-Hydroxy Vitamin D Levels Predict the Severity of Multisystem Inflammatory Syndrome in Children and COVID-19?
title Can Serum 25-Hydroxy Vitamin D Levels Predict the Severity of Multisystem Inflammatory Syndrome in Children and COVID-19?
title_full Can Serum 25-Hydroxy Vitamin D Levels Predict the Severity of Multisystem Inflammatory Syndrome in Children and COVID-19?
title_fullStr Can Serum 25-Hydroxy Vitamin D Levels Predict the Severity of Multisystem Inflammatory Syndrome in Children and COVID-19?
title_full_unstemmed Can Serum 25-Hydroxy Vitamin D Levels Predict the Severity of Multisystem Inflammatory Syndrome in Children and COVID-19?
title_short Can Serum 25-Hydroxy Vitamin D Levels Predict the Severity of Multisystem Inflammatory Syndrome in Children and COVID-19?
title_sort can serum 25-hydroxy vitamin d levels predict the severity of multisystem inflammatory syndrome in children and covid-19?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234062/
https://www.ncbi.nlm.nih.gov/pubmed/36794864
http://dx.doi.org/10.4274/jcrpe.galenos.2023.2022-10-1
work_keys_str_mv AT ekemenkelesyıldız canserum25hydroxyvitamindlevelspredicttheseverityofmultisysteminflammatorysyndromeinchildrenandcovid19
AT yılmazdilek canserum25hydroxyvitamindlevelspredicttheseverityofmultisysteminflammatorysyndromeinchildrenandcovid19
AT tasarselin canserum25hydroxyvitamindlevelspredicttheseverityofmultisysteminflammatorysyndromeinchildrenandcovid19
AT ustundaggulnihan canserum25hydroxyvitamindlevelspredicttheseverityofmultisysteminflammatorysyndromeinchildrenandcovid19
AT sahinaslıhan canserum25hydroxyvitamindlevelspredicttheseverityofmultisysteminflammatorysyndromeinchildrenandcovid19
AT tuzaysegulelvan canserum25hydroxyvitamindlevelspredicttheseverityofmultisysteminflammatorysyndromeinchildrenandcovid19
AT arslanmadenaslıhan canserum25hydroxyvitamindlevelspredicttheseverityofmultisysteminflammatorysyndromeinchildrenandcovid19
AT karaaksayahu canserum25hydroxyvitamindlevelspredicttheseverityofmultisysteminflammatorysyndromeinchildrenandcovid19
AT colakayfer canserum25hydroxyvitamindlevelspredicttheseverityofmultisysteminflammatorysyndromeinchildrenandcovid19
AT karadagonceleda canserum25hydroxyvitamindlevelspredicttheseverityofmultisysteminflammatorysyndromeinchildrenandcovid19